NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
EvoTears® OMEGA - EvoTears®
Management - Novaliq
Anterior Segment Company Showcase - Novaliq GmbH
Novaliq's NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand | Business Wire
OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE
Anterior Segment Company Showcase - Novaliq GmbH
Startseite - Novaliq
novaliq - Twitter Search / Twitter
Products - Novaliq
Products - Novaliq
Novaliq completes enrollment in second Phase 3 study of candidate to treat dry eye